The United Laboratories International Holdings Limited (UNJ)

Overview

The United Laboratories International Holdings Limited is a multifaceted investment holding company primarily focused on the pharmaceutical sector. Established in 1990 and based in Yuen Long, Hong Kong, the company dedicates its operations to the research and development, manufacturing, distribution, and sale of a wide range of pharmaceutical products. The United Laboratories operates across three key segments: Bulk Medicine, Intermediate Products, and Finished Products, ensuring a comprehensive approach to pharmaceutical development and supply. It boasts an international presence, with operations spanning the People's Republic of China, Europe, India, the Middle East, South America, Asian regions, and other international markets. Beyond its manufacturing and distribution capabilities, the company is involved in trademark holding, pharmaceutical product trading, and providing management services.

Products and Services

The United Laboratories International Holdings Limited offers an extensive portfolio of pharmaceutical products and services, catering to a variety of health concerns and medical needs. Key offerings include:

• Oral Antibiotics: Pharmaceutical drugs designed to combat bacterial infections when administered orally, providing a foundational treatment option in antimicrobial therapy.
• Antimicrobials for Injection: Injectable drugs targeting a wide range of bacterial infections, suitable for more severe or systemic bacterial infections.
• Anti-cold Products: Medications aimed at alleviating symptoms associated with the common cold, including congestion, headache, and fever.
• Cough Medicines: Therapeutics developed to relieve coughing, whether caused by the common cold, flu, or other respiratory conditions.
• Ophthalmic Drugs: Medications specifically formulated for treating eye conditions, ranging from infections to inflammation.
• Antiviral Drugs: Medications used to treat viral infections, designed to inhibit the development of the virus within the human body.
• Anti-hepatitis B Drugs: Treatments targeting Hepatitis B virus, aiming to reduce virus replication and improve liver health.
• Diabetes Drugs: Pharmaceuticals intended to control blood sugar levels in individuals with diabetes, promoting better management of the condition.
• Skin Drugs for External Use: A range of topical medications for treating various skin conditions, including infections, inflammations, and allergic reactions.
• Cardiovascular and Cerebrovascular Drugs: Medications aimed at treating conditions related to the heart and blood vessels, including hypertension and stroke prevention.
• Amoxicillin Products: A category of antibiotics known for their effectiveness against a variety of bacterial infections, available in different formulations.
• Nervous System Drugs: Medications that affect the nervous system, used to treat neurological conditions such as epilepsy, Parkinson’s disease, and anxiety disorders.
• Vitamins: Essential nutrients that are crucial for maintaining overall health, supporting bodily functions, and preventing deficiencies.
• Veterinary Drugs: Pharmaceuticals specifically designed for the treatment of animals, addressing a wide range of veterinary health issues.
• Vacant Gelatin Capsules: Empty capsules made of gelatin, used for encapsulating various medicines, enabling easy administration and dosage precision.
• Active Pharmaceutical Ingredients (APIs) and Intermediate Products: Chemical components and intermediaries used in the manufacture of pharmaceutical drugs, providing essential building blocks for formulations.

In addition to these products, The United Laboratories also engages in the manufacturing and sales of soft capsules casings, holds trademarks, and trades in pharmaceutical products, thereby expanding its influence across the pharmaceutical supply chain.